![]() |
Multiple Sclerosis |
Free Subscription
1 J Neuroimmunol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Multiple Sclerosis is free of charge.
Relapsing-remitting multiple sclerosis as a potential consequence of thalidomide
treatment: A case report.
J Neuroimmunol. 2025;404:578606.
PubMed
Abstract available
Measuring cognitive change in secondary progressive MS: an analysis of the ASCEND
cognition substudy.
J Neurol. 2025;272:338.
PubMed
Abstract available
Movement disorders in relapsing and progressive MS: A comprehensive prospective
evaluation of a large real-life cohort.
J Neurol Sci. 2025;472:123468.
PubMed
Abstract available
Risk factors for incident peripartum mental illness in multiple sclerosis.
Mult Scler. 2025 Apr 18:13524585251330109. doi: 10.1177/13524585251330109.
PubMed
Abstract available
Addressing patient-reported cognitive impairment in multiple sclerosis clinical
practice: A challenging endeavor.
Mult Scler. 2025 Apr 18:13524585251334488. doi: 10.1177/13524585251334488.
PubMed
Abstract available
Frequency and potential risk factors associated with the development of
asymptomatic T2 hyperintense cervical spine lesions on MRI in patients with
relapsing-remitting multiple sclerosis.
Mult Scler. 2025 Apr 17:13524585251331405. doi: 10.1177/13524585251331405.
PubMed
Abstract available
Hypnosis and mindfulness audio recordings for reducing fatigue in individuals
with multiple sclerosis: A randomized controlled study.
Mult Scler. 2025 Apr 17:13524585251329820. doi: 10.1177/13524585251329820.
PubMed
Abstract available
Slower retinal thinning over a year predicts continuous NEDA status at follow-up
in multiple sclerosis: A longitudinal OCT study.
Mult Scler. 2025 Apr 12:13524585251332499. doi: 10.1177/13524585251332499.
PubMed
Abstract available
Emphasizing complementary in "Investigating the complementary value of OCT to MRI
in cognitive impairment in relapsing-remitting multiple sclerosis".
Mult Scler. 2025 Apr 12:13524585251329800. doi: 10.1177/13524585251329800.
PubMed
Response to letter to the editor: 'Investigating the complementary value of OCT
to MRI in cognitive impairment in relapsing-remitting multiple sclerosis'.
Mult Scler. 2025 Apr 12:13524585251329787. doi: 10.1177/13524585251329787.
PubMed
Subcutaneous Ocrelizumab in Patients With Multiple Sclerosis: Results of the
Phase 3 OCARINA II Study.
Neurology. 2025;104:e213574.
PubMed
Abstract available
Updated Multiple Sclerosis Incidence in France, 2011-2021.
Neurology. 2025;104:e213586.
PubMed
Abstract available
Sensitivity of multi-parametric quantitative magnetic resonance imaging for
multiple sclerosis pathology.
PLoS One. 2025;20:e0318415.
PubMed
Abstract available
Psychoses onset in multiple sclerosis: A systematic review and meta-analysis.
Rev Neurol (Paris). 2025 Apr 15:S0035-3787(25)00497.
PubMed
Abstract available
Thank you for your interest in scientific medicine.